4-Phosphopantetheine transferases (PPTases) transfer the 4-phosphopantetheine moiety of coenzyme A onto a conserved serine residue of acyl carrier proteins (ACPs) of fatty acid and polyketide synthases as well as peptidyl carrier proteins (PCPs) of nonribosomal peptide synthetases. This posttranslational modification converts ACPs and PCPs from their inactive apo into the active holo form. We have investigated the 4-phosphopantetheinylation reaction in Bacillus subtilis, an organism containing in total 43 ACPs and PCPs but only two PPTases, the acyl carrier protein synthase AcpS of primary metabolism and Sfp, a PPTase of secondary metabolism associated with the nonribosomal peptide synthetase for the peptide antibiotic surfactin. We identified and cloned ydcB encoding AcpS from B. subtilis, which complemented an Escherichia coli acps disruption mutant. B. subtilis AcpS and its substrate ACP were biochemically characterized. AcpS also modified the D-alanyl carrier protein but failed to recognize PCP and an acyl carrier protein of secondary metabolism discovered in this study, designated AcpK, that was not identified by the Bacillus genome project. On the other hand, Sfp was able to modify in vitro all acyl carrier proteins tested. We thereby extend the reported broad specificity of this enzyme to the homologous ACP. This in vitro cross-interaction between primary and secondary metabolism was confirmed under physiological in vivo conditions by the construction of a ydcB deletion in a B. subtilis sfp ؉ strain. The genes coding for Sfp and its homolog Gsp from Bacillus brevis could also complement the E. coli acps disruption. These results call into question the essential role of AcpS in strains that contain a Sfp-like PPTase and consequently the suitability of AcpS as a microbial target in such strains.
We have investigated the 4-phosphopantetheinylation reaction in Bacillus subtilis, an organism containing in total 43 ACPs and PCPs but only two PPTases, the acyl carrier protein synthase AcpS of primary metabolism and Sfp, a PPTase of secondary metabolism associated with the nonribosomal peptide synthetase for the peptide antibiotic surfactin. We identified and cloned ydcB encoding AcpS from B. subtilis, which complemented an Escherichia coli acps disruption mutant. B. subtilis AcpS and its substrate ACP were biochemically characterized. AcpS also modified the D-alanyl carrier protein but failed to recognize PCP and an acyl carrier protein of secondary metabolism discovered in this study, designated AcpK, that was not identified by the Bacillus genome project. On the other hand, Sfp was able to modify in vitro all acyl carrier proteins tested. We thereby extend the reported broad specificity of this enzyme to the homologous ACP. This in vitro cross-interaction between primary and secondary metabolism was confirmed under physiological in vivo conditions by the construction of a ydcB deletion in a B. subtilis sfp ؉ strain. The genes coding for Sfp and its homolog Gsp from Bacillus brevis could also complement the E. coli acps disruption. These results call into question the essential role of AcpS in strains that contain a Sfp-like PPTase and consequently the suitability of AcpS as a microbial target in such strains.
4Ј-Phosphopantetheine (Ppant)
1 is an essential prosthetic group of several acyl carrier proteins involved in pathways of primary and secondary metabolism. These include acyl carrier proteins (ACPs) of fatty acid synthases (FASs), ACPs of polyketide synthases (PKSs), and peptidyl carrier proteins (PCPs) and aryl carrier proteins of nonribosomal peptide synthetases (NRPSs) (1, 2) . The free thiol moiety of Ppant serves to covalently bind the acyl reaction intermediates as thioesters during the multistep assembly of the monomeric precursors, typically acetyl, malonyl, and aminoacyl groups. Ppant fulfills two demands in these biosynthetic pathways. First, the intermediates remain covalently tethered to the multifunctional enzyme templates in an energy-rich linkage. Second, the flexibility and length of Ppant (about 20 Å) facilitates the transport of the intermediates to the spatially distinct reaction centers. The Ppant moiety is derived from coenzyme A (CoA) and posttranslationally transferred onto an invariant serine side chain. This Mg 2ϩ -dependent conversion of the apoproteins to the holoproteins is catalyzed by the 4Ј-phosphopantetheine transferases (PPTases) (1, 2) (see Fig. 1 ).
Most organisms that employ more than one Ppant-dependent pathway also contain more than one PPTase. For example, Escherichia coli has three PPTases, namely the acyl carrier protein synthase AcpS involved in fatty acid synthesis, EntD involved in synthesis of the siderophore enterobactin, and the gene product of yhhU, with as yet unknown physiological function (1, 3) . Interestingly, PPTases of different pathways can have overlapping selectivity for their cognate acyl carrier protein partner. In E. coli, AcpS and EntD have reciprocal specificities, with AcpS only recognizing ACP and EntD only accepting the PCPs of the enterobactin NRPS (1) . In contrast, Sfp, the PPTase of the surfactin NRPS of Bacillus subtilis, was shown to also phosphopantetheinylate heterologous ACPs of FASs and PKSs (1, 4, 5) .
PPTases have been classified in three groups according to their sequence homologies and substrate spectrum. The first group is the AcpS type with AcpS of Escherichia coli as the name-giving prototype. PPTases of this type are about 120 aa in length, are found in almost all microorganisms for the modification of fatty acid ACP, and were shown to accept as substrate also ACPs of type II PKS systems (6) . The PPTase Sfp of B. subtilis is the prototype of the second group. Enzymes of this type are about 240 aa in length and have mostly been found associated with the gene clusters for nonribosomal peptide synthesis. The well characterized Sfp exhibits an extraordinarily broad substrate specificity and could modify all acyl carrier protein substrates tested, including PCPs of NRPS as well as ACPs of FAS and PKS. The third group is an integrated PPTase found as the C-terminal domain of the multifunctional FAS2, for example in Saccharomyces cerevisiae (7) . This classification has recently been further supported by structural studies. The monomeric Sfp was found to fold in two domains with similar topology (8) . In Sfp, CoA is bound at the interface of this pseudohomodimer. Interestingly, both domains exhibit sequence homology to members of the AcpS group, which are only half the size of Sfp. Two highly similar structures of enzymes of the AcpS group have recently been reported, namely AcpS of B. subtilis (9) and Streptococcus pneumoniae (10) . In both structures, AcpS forms a trimer. As was already suggested from the Sfp structure, each AcpS monomer has the same folding as the two Sfp subdomains. However, since three AcpS subunits are present in this structure, three CoA binding sites are generated at the subunit interfaces.
In this work, we set out to characterize the 4Ј-phosphopantetheinylation reactions in B. subtilis. This organism is of special interest in this respect, because it contains a large number of Ppant-dependent pathways of primary and secondary metabolism but only two PPTases, AcpS and Sfp (see Fig.  2 ). We report on the biochemical characterization of AcpS and the identification of a second acyl carrier protein in B. subtilis, designated AcpK, and define the specificity of the two PPTases for the different acyl carrier proteins. As suggested from the in vitro data, we found that AcpS of B. subtilis is not essential in strains that are sfp ϩ . From these results and from genetic complementation studies in E. coli, we present a refined model for the substrate spectrum of PPTases of the AcpS and Sfp type and consequences for their suitability as microbial targets.
EXPERIMENTAL PROCEDURES
General Techniques-E. coli was grown on LB medium. B. subtilis was usually grown and maintained on Difco sporulation medium (11); however, for preparations of chromosomal DNA, it was also grown on LB medium. Antibiotics were used at the following concentrations for E. coli: ampicillin, 100 g/ml; spectinomycin, 100 g/ml; kanamycin, 60 g/ml (25 g/ml for M15/pREP4 strains). For B. subtilis, the following concentrations were used: chloramphenicol, 10 g/ml; spectinomycin, 100 g/ml; MLS, erythromycin (1 g/ml) plus lincomycin (25 g/ml).
For E. coli techniques, such as transformation, plasmid preparation, and P1 phage transduction, standard protocols were used (12, 13) . Vent polymerase (New England Biolabs, Schwalbach, Germany) was used to amplify gene fragments for cloning and expression purposes, and the Expand Long Range PCR system (Roche Molecular Biochemicals) was used for control PCRs and for the amplification of fragments used for transformations. Oligonucleotides were purchased from MWG Biotech. Gene Knockout and Gene Introduction into E. coli and B. subtilisFor manipulations in the chromosome of E. coli, we used the polA strain HSK42, which is unable to replicate ColE1-based plasmids. When transformed with such a plasmid, integration into the chromosome must occur under selective conditions. Double crossover transformants were identified by testing for sensitivity against ampicillin and were confirmed by PCR analysis of chromosomal DNA (for the nrdD locus, oligonucleotides E1 (5Ј-GATTATTGCGCCACTGTTGC-3Ј) and E2 (5Ј-TCATTTTCCCACACGCCGAG-3Ј), annealing at the nrdD gene, were used). B. subtilis strains were transformed according to the protocol of Klein et al. (14) . For PCR analysis of new genotypes, chromosomal DNA was prepared.
Construction of Plasmids-All plasmids used in this study are summarized in Table I . Construction of the integration plasmid pUC18-nrdD::acps-spc for E. coli was as follows. The vector pET22b-acps (15) was linearized with HindIII and ligated with the spectinomycin resistance cassette (spc ϩ ) excised from pDG1726 (16) with HindIII. The obtained plasmid pET22b-acps-spc was cut with BglII and SphI, and the excised fragment was cloned into BamHI-and SphI-treated pTZ18R. The resulting plasmid pTZ18R-acps-spc served as a template in a PCR with oligonucleotides 5Ј-ATAGTTAACGCGCGTTGGCCGAT-TC-3Ј and 5Ј-ATAGTTAACGCCTCTTCGCTATTACGC-3Ј to amplify a fragment that contained acps under control of the lac promotor of pTZ18R and spc ϩ . This fragment was cloned blunt-ended into pUC18-nrdD, which was treated with EcoRV, to give pUC18-nrdD::acps-spc.
FIG. 2.
Genetic maps of the E. coli and B. subtilis genomes. The genetic loci relevant for this study are shown on the genetic maps of E. coli (A) and B. subtilis (B). Genes encoding PPTases as well as the nrdD and amyE loci, that were used to introduce second copies of acps and ydcB, respectively, are marked outside the circle. The insertion and deletion strategy for the disruption of E. coli acps and B. subtilis ydcB is indicated above these gene loci. Genes and gene cluster-encoding acyl carrier proteins, their numbers given in parentheses, are shown inside the circle.
FIG. 1. Activity of PPTases.
PPTases catalyze the posttranslational transfer of the 4Ј-phosphopantetheine moiety of CoA onto a conserved serine residue within ACPs or PCPs. Thereby, the acyl carrier protein is converted from its inactive apo form into the active holo form. The reaction is dependent on Mg 2ϩ and yields 3Ј,5Ј-ADP as a second product.
Construction of the Disruption Plasmid pTZ18R-5Ј-acps:
:kan-3Ј for E. coli-Using oligonucleotides E3 (5Ј-ATATCTAGACCATGACGTATCG-TTATC-3Ј) and E4 (5Ј-ATACCATGGTTCTACTCTGGAAGTAGAG-3Ј), a 2080-kb fragment was amplified from chromosomal DNA of E. coli K-12 that comprised 990 bp upstream and 692 bp downstream of acps. This fragment was cloned into pTrc99a using the NcoI and XbaI sites introduced with the oligonucleotides. The resulting plasmid pTrc99a-5Ј-acps-3Ј was then linearized at the single SacI site, which is localized at position 251 of the 381-bp acps gene. The kanamycin resistance cassette (kan ϩ ) was excised from vector pDG782 (16) with EcoRI and BglII and cloned into pTZ18R to give pTZ18R-kan. The kan ϩ cassette was then amplified by PCR with oligonucleotides 5Ј-ATAGAGCTCGACTCACTATAGG-GAATTC-3Ј and 5-Ј-ATAGAGCTCTAAAACGACGGCCAGTG-3Ј from pTZ18R-kan, cut with SacI and ligated with the linearized fragment of pTZ18R-5Ј-acps-3Ј to give pTrc99a-5Ј-acps::kan-3Ј.
Construction of pTZ18R-ydcB-ydcB was amplified by PCR from chromosomal DNA of B. subtilis JH642 using oligonucleotides 5Ј-ATA-TAAGCTTCATTTAAATAGTACGTACGC-3Ј and 5Ј-TATAAGATCTC-ACTATCAAATATATGAGTGG-3Ј and cloned blunt-ended into pTZ18R that was linearized with HincII. The right orientation of ydcB under control of the lac promotor of pTZ18R-ydcB was verified by restriction analysis and sequencing.
Construction of pDR67-ydcB-The acps gene of B. subtilis was cut out of pTZ18R-ydcB with HindIII and BglII and cloned between the HindIII and BglII sites of pDR67 to give pDR67-ydcB. pDR67 lacks an origin of replication for B. subtilis but can integrate into the amyE locus of the genome via the amyE front and amyE back fragments upstream and downstream of the multiple cloning site of the plasmid. The cat ϩ cassette conferring chloramphenicol resistance, which is also located between the two amyE fragments, serves to select for the integration. Inserts cloned into the multiple cloning site are under the control of the weak and isopropyl-␤-D-thiogalactopyranoside-inducible spac promotor, which is leaky in rich media according to our experience.
Construction of the Disruption Plasmid for ydcB of B. subtilis pTZ18R-5Ј-⌬ydcB::spc-3Ј-To clone flanking regions of ydcB, a fragment from 992 bp upstream to 994 bp downstream of ydcB was amplified from chromosomal DNA of B. subtilis MR168 by PCR with oligonucleotides 5Ј-ATAGGATCCAGCCTTCATTTTAAAGTGG-3Ј (primer 1 in Fig. 6 ) and 5Ј-AATTCTGCAGCAATCTGGGCTTTTTCCTG-3Ј (primer 2 in Fig. 6 ) and cloned into the BamHI and PstI sites of pTZ18R. The resulting plasmid pTZ18 -5Ј-ydcB-3Ј then served as a template for an inverse PCR with oligonucleotides 5Ј-ATAGATATCATGTATGATAAC-CTCC-3Ј and 5Ј-ATAGATATCCTAGTCTGCATATTAGGG-3Ј (introducing EcoRV restriction sites) to replace the entire ydcB with the spc ϩ cassette of pDG1726 (16) , which was excised with EcoRV and HincII, to give pTZ18R-5Ј-⌬ydcB::spc-3Ј.
Construction of pTZ19-gsp-The HindIII-PstI fragment containing the gsp gene was excised from pGspϩ (17) and ligated into pTZ19R to give pTZ19-gsp.
Construction of pQE60-ACP-The acpA gene encoding ACP was PCR-amplified with oligonucleotides 5Ј-AATTCCATGGCAGACACAT-TAGAGCGT-3Ј and 5Ј-TTTTGGATCCTTGCTGGTTTTGTATGTAGTT-CAC-3Ј from chromosomal DNA of B. subtilis MR168 and ligated into the NcoI and BamHI sites of pQE60 to give the expression plasmid pQE60-acpA. The encoded recombinant protein carries the C-terminal tag GSRSHHHHHH.
Construction of pQE60-acpK-The acpK gene was amplified by PCR with oligonucleotides 5Ј-TATCCATGGATAAACAGAGAATCTTTG-3Ј and 5Ј-TATAGATCTGGCAGATTGCACTTTGTC-3Ј from chromosomal DNA of B. subtilis MR168. The amplified fragment was digested with NcoI and BglII and ligated into the NcoI and BamHI sites of pQE60 to create the expression plasmid pQE60-acpK encoding the recombinant AcpK with a C-terminal tag GSGSHHHHHH.
Construction of pQE60-dltC-The dltC gene encoding the D-alanyl carrier protein (DCP) was amplified by PCR with oligonucleotides 5Ј-ATACCATGGATTTTAAACAAGAGG-3Ј and 5Ј-ATAAGATCTTTTCAA-CTCAGACAGCT-3Ј from chromosomal DNA of B. subtilis MR168 and ligated into the NcoI and BglII sites of pQE60. The resulting plasmid pQE60-dltC encodes the recombinant DCP with a C-terminal tag RSHHHHHH.
Overproduction and Purification of Recombinant Proteins-E. coli M15/pREP4 was transformed with pTZ18-ydcB to give strain RF3. 5 ml of an overnight culture of RF3 in LB were used to inoculate 500 ml of the same medium. Cells were grown at 37°C and 300 rpm until an A 600 of 0.7 was reached. The culture was then induced with 0.25 mM isopropyl-␤-D-thiogalactopyranoside and grown at 37°C and 300 rpm for 3 h. Cells were harvested by centrifugation at 4,500 ϫ g at 4°C, resuspended in 50 mM Tris/HCl (pH 7.8), and disrupted by three passages through a cooled French pressure cell. The resulting cell extract was centrifuged at 36,000 ϫ g at 4°C for 30 min. Ammonium sulfate was added to the supernatant to a final concentration of 25% saturation. The resulting protein suspension was stirred at 4°C for 1 h and centrifuged at 36,000 ϫ g and 4°C for 45 min. Subsequently, the pellet was discarded, and ammonium sulfate was added to the supernatant to a final concentration of 40% saturation. The suspension was stirred again at 4°C for 1 h and centrifuged as described above. The resulting pellet was resuspended in 50 mM Tris/HCl, 1 M (NH 4 ) 2 SO 4 (HIC buffer A, pH 7.8) and centrifuged as described above, and the supernatant was applied to a High-Load TM 26/10 phenyl-Sepharose column (Amersham Pharmacia Biotech) that had been equilibrated with HIC buffer A. The column was washed with buffer A at a flow rate of 1 ml/min, and the protein was eluted with a linear gradient of 1.0 to 0 M (NH 4 ) 2 SO 4 in HIC buffer A; 4-ml fractions were collected. The presence of AcpS in the fractions was detected by SDS-polyacrylamide gel electrophoresis analysis (15% Laemmli gels). Fractions containing AcpS were pooled and concentrated by 40% (NH 4 ) 2 SO 4 precipitation as described above. The resulting pellet was resuspended in 50 mM NaH 2 PO 4 /NaHPO 4 (pH 7.0), centrifuged as described above, and applied to a Superdex TM G75 26/60 gel filtration column (Amersham Pharmacia Biotech) that had been equilibrated with 50 mM NaH 2 PO 4 /NaHPO 4 (pH 7.0); 4-ml fractions were collected. Fractions containing AcpS were collected, pooled, and applied to a 6-ml Resource TM 15 S column (Amersham Pharmacia Biotech) that had been equilibrated with 50 mM NaH 2 PO 4 /NaHPO 4 (CAT buffer A, pH 7.0). The column was washed with CAT buffer A, and the protein was eluted with a linear gradient of 0 -0.5 M NaCl in CAT buffer A while collecting 2-ml fractions. The AcpS-containing fractions were collected and applied to a Superdex TM G75 26/60 gel filtration column that had been equilibrated with 50 mM Tris/HCl, 2 mM dithiothreitol (assay buffer, pH 8.8). Fractions containing AcpS were collected, analyzed by matrix-assisted laser desorption/ionization time-offlight mass spectrometry, adjusted with glycerol to a final concentration of 10% (v/v), and stored in small aliquots at Ϫ80°C.
E. coli M15/pREP4 was transformed with pQE60-acpA, pQE60-acpK, and pQE60-dltC to give strains RF1, HM403, and RF4, respectively, for the production of the His 6 fusion proteins ACP, AcpK, and DCP. Cells were grown, induced, harvested, and disrupted, and the crude cell extract was centrifuged as described above for RF3. Protein purification using Ni 2ϩ affinity chromatography was carried out as previously described (18) . Purified proteins were dialyzed against assay buffer, brought to 10% glycerol (v/v), and stored at Ϫ80°C. TycC3-PCP, hereafter referred to as PCP, and Sfp-His 6 were produced and purified as previously described (8, 19 Reactions were stopped by the addition of 0.8 ml of ice-cold trichloroacetic acid (10%) and 15 l of bovine serum albumin (25 mg/ml). Precipitated protein was collected by centrifugation at 13,000 rpm and 4°C for 15 min. The pellet was washed twice with 0.8 ml of ice-cold trichloroacetic acid and resuspended in 200 l of formic acid. The resulting suspension was mixed with 3.5 ml of Rotiszint Eco Plus scintillation fluid (Roth) and counted using a 1900CA Tri-Carb liquid scintillation analyzer (Packard).
For kinetic studies, reaction mixtures contained, unless otherwise indicated, 50 mM Tris/HCl, pH 8.8 (75 mM MES, pH 6.0, in the case of Sfp), 12.5 mM MgCl 2 , 2 mM dithiothreitol, 2-200 M apo-ACP of B. subtilis (apo/holo mixture) or 2-60 M AcpK, 2-1000 M CoA, and 5.6 nM AcpS of B. subtilis or 10 nM Sfp and were incubated at 37°C for 10 -30 min. The reaction was stopped, and the protein was precipitated by the addition of trichloroacetic acid (final concentration 10%). The amount of holo-ACP and AcpK formed was determined by an HPLC method. This method was adapted from a method described previously (15) . Reaction mixtures (800 l each) were, after the addition of trichloroacetic acid, centrifuged for 30 min at 13,000 rpm and 4°C. The supernatant was discarded, and the protein pellet resuspended in 120 l of 50 mM Tris/HCl, pH 8.8. A 100-l sample of this solution was injected onto an analytical Nucleosil 250 C 18 -column (reversed phase; Macherey & Nagel) that had been equilibrated with 0.1% trifluoroacetic acid. Absorbance at 220 nm was monitored. The column was eluted with a 1.2-ml linear gradient to 60% solvent B (methanol in 0.1% trifluoroacetic acid) followed by a 7.2-ml linear gradient to 100% solvent B at 0.3 ml/min. Under these conditions, holo-ACP migrated faster than apo-ACP (24.3 and 25.2 min, respectively). The amount of holo-ACP formed was determined by comparing the peak area of the holo-ACP formed with those of both apo-and holo-ACP and subtracting the amount of holo-ACP that was already present after the heterologous expression of the protein in E. coli (see "Results"). Apo-AcpK and holo-AcpK were separated in a similar manner using the same column and a 15-ml linear gradient to 80% solvent C (isopropyl alcohol in 0.1% trifluoroacetic acid) followed by a 0.6-ml linear gradient to 95% solvent C at 0.3 ml/min. Holo-AcpK and apo-AcpK eluted at retention times of 53.9 and 54.8 min.
To determine K m and k cat values of AcpS and Sfp for apo-ACP and apo-AcpK, reaction mixtures (in triplicate) contained 1 mM CoA, 2-200 M apo-ACP, or 2-60 M apo-AcpK and either 5.6 nM AcpS or 10 nM Sfp. For the determination of the K m value of AcpS for CoA, the reaction conditions were the same as described above except that the concentration of apo-ACP was kept at 200 M, and concentrations of CoA were 2-500 M. The formation of holo carrier protein was measured by the HPLC method in all cases. Carrier proteins were dialyzed before the assay against the respective assay buffer (50 mM Tris/HCl, pH 8.8, in the case of AcpS and 75 mM MES, pH 6.0, in the case of Sfp). (20) , a disruption mutant can only be generated when a complementing gene is present in trans. We therefore decided to first integrate a second copy of acps in another locus of the E. coli chromosome and then disrupt the gene at its natural locus (at 58 min; see Fig. 2A ) with a kan ϩ cassette. The acps::kan ϩ genotype was then transduced using P1 phage into other E. coli strains carrying in trans a PPTase gene to be tested for acps complementation activity. For manipulations of the chromosome of E. coli, we used a polA mutant strain, HSK 42, that is unable to replicate ColE1-based plasmids and thus allows selection of integration into the chromosome. Double crossover integrations were identified by marker loss and PCR analysis with flanking primers. acps is the second gene in a bicistronic operon with pdxJ (the former name of acps was dpj, for downstream of pdxJ) and is followed by a termination loop (15, 20) . A disruption of acps was therefore not expected to exert polar effects on neighboring genes. The nrdD locus at 96 min (see Fig.  2A ) was chosen for the integration of a second copy of the acps gene into the E. coli chromosome. nrdD encodes the anaerobic deoxyribonucleotide reductase, which is not essential under the conditions used here (21) . Transformation of HSK42 with the disruption plasmid pTrc99a-5Ј-acps::kan-3Ј and selection on LB plates with kanamycin yielded Km r transformants, which were exclusively found after restreaking to be also Ap r and thus had integrated the plasmid only by a single crossover event, leaving the original acps gene intact. This finding confirmed the essential nature of the acps gene and the necessity to first introduce a second copy of the gene. To this end, HSK42 was first transformed with the integration plasmid pUC18-nrdD::acps-spc, and transformants were selected on LB plates with spectinomycin. About 10% of these were candidates for double crossover integration, since they were Ap s . This genotype was confirmed by PCR using oligonucleotides E1 and E2. Only the fragment nrdD::acps-spc ϩ and not the wild-type fragment nrdD was obtained. The latter was obtained in the control using chromosomal DNA of HSK42. One transformant, HM0139 (see Table II for a list of strains), was chosen for further work and transformed with plasmid pTrc99a-5Ј-acps::kan-3Ј to disrupt the acps gene. Identification of the ydcB Gene Encoding AcpS of B. subtilis and Its Genetic Characterization-At the beginning of this work, the gene encoding the ACP synthase (AcpS) of B. subtilis was not identified or characterized. By homology searches, we identified ydcB, which was revealed by the B. subtilis genome sequencing project (22) as the putative gene coding for AcpS (33% identity to E. coli AcpS). ydcB is located at 44°of the Bacillus genome (see Fig. 2B ), 366 bp in length, and encodes a protein of 121 aa (13.7 kDa).
RESULTS

Construction of an E. coli acps Disruption Mutant as a Genetic Tool-Since acps is an essential gene in E. coli
We assumed that AcpS of B. subtilis should complement the corresponding activity in E. coli and therefore attempted to disrupt acps of E. coli expressing ydcB in trans. For this purpose, E. coli K-12 strain MG1655 was transformed with pTZ18R-ydcB to give strain HM0172. To test for complementation activity, the acps::kan ϩ genotype was then transduced with the P1 lysate of HM0145, and transductants were selected on LB plates containing ampicillin and kanamycin. Indeed, Km r colonies could be obtained overnight using HM0172 as recipient strain, whereas no Km r -colonies appeared in the control (strain HM0169, MG1655 with plasmid pTZ18R) under these conditions. The Km r colonies were Sp s , indicating that the nrdD::acps-spc ϩ genotype was not co-transduced. Both genotypes were confirmed by PCR (not shown).
Sfp and Other Members of the Sfp Family Can Also Complement AcpS of E. coli in Vivo-
We also tested the ability of PPTases of the Sfp type to modify noncognate ACP substrates under heterologous in vivo conditions. To this end, plasmids pUC8-sfp and pTZ19-gsp were transformed into E. coli K-12 to give the strains HM0170 and HM0171, respectively. As described above, the P1 lysate of HM0145 was then used to transduce the acps::kan ϩ genotype. In both cases, using HM0170 and HM0171, Km r transductants (which were Sp S ) were obtained overnight, whereas no Km r colonies could be observed with the control strain HM0169. Further analysis of the transductants by PCR confirmed their acps::kan ϩ genotype. Thus, the PPTases Sfp and Gsp of secondary metabolism from B. subtilis and Bacillus brevis can also complement AcpS of E. coli's primary metabolism.
Interestingly, Km r and Sp s colonies also appeared in the experiments using control strain HM0169 after a prolonged time period (after 2-3 days at 37°C). These colonies were confirmed by PCR to be true transductants, since they were acps::kan ϩ . Obviously, the same suppressor mutations that complement the lethal acps disruption were selected as previously described by Lam et al. for a conditional mutant of the acps gene (formerly dpj) under nonpermissive conditions (20, 23) . In agreement with the results by these authors, most of the transductants displayed a very mucous morphology on LB plates. Suppressor mutations can occur in the lon gene and at another location in the chromosome (20, 23) , presumably in the gene yhhU encoding a PPTase of unknown function (3) .
Overproduction and Purification of B. subtilis AcpS, ACP, AcpK, and DCP-Pure B. subtilis AcpS was obtained by heterologous overexpression of the ydcB gene in E. coli and subsequent four-column purification as described under "Experimental Procedures." ACP, DCP, and AcpK (see below) of B. subtilis were produced as C-terminal His 6 tag fusion proteins and purified by affinity chromatography. SDS-polyacrylamide gel electrophoresis analysis (not shown) showed that two bands were obtained in the case of ACP and DCP, pointing to partial apo to holo conversion by E. coli AcpS during heterologous expression. In contrast to a report on the isolation and cloning of the acpA gene in E. coli (24) , neither the production of ACP nor of the other proteins seemed to significantly inhibit growth of E. coli cells.
Biochemical Characterization of B. subtilis AcpS-To determine the catalytic activity of B. subtilis AcpS, an HPLC assay was applied. The recombinant substrate ACP of B. subtilis was determined by the HPLC method to be present in a ratio of 84% apo to 16% holo form after heterologous production in E. coli. Kinetic constants were determined through a Michaelis-Menten fit of the data sets (see Fig. 3 and Table III) . Interestingly, first saturation occurred between 2 and 8 M apo-ACP (Fig.  3A) , but velocity values began to increase when the apo-ACP concentration was raised to 20 M apo-ACP. Therefore, two different K m and k cat values could be determined. The first K m for apo-ACP concentrations between 2 and 8 M was 0.2 Ϯ 0.3 M, with the k cat being 22 Ϯ 2 min Ϫ1 (Fig. 3A) , and the second K m was determined as 68 Ϯ 11 M with a k cat of 125 Ϯ 9 min Ϫ1 for apo-ACP concentrations between 20 and 200 M (Fig. 3B) . The K m of AcpS for CoA was determined in essentially the same fashion, except that the apo-ACP concentration was kept constant at 200 M, while the CoA concentration was varied between 5 and 500 M. The Michaelis-Menten fit of the experimental data set yielded a K m of 5.4 Ϯ 1.5 M and a k cat of 109 Ϯ 5 min Ϫ1 (Fig. 3C ).
Protein Partners of AcpS and Sfp: ACP, PCP, and DCP-
Since Sfp was reported to be of broad specificity, we assumed that it would also modify the ACP of B. subtilis. However, this experiment was intriguing, because a higher degree of specialization would be conceivable for the homologous substrates of the same organism. All cases of broad specificity of Sfp were demonstrated for heterologous acyl carrier proteins. Nevertheless, as shown in Fig. 4 , Sfp also efficiently recognizes and modifies ACP of B. subtilis. The dispensable PPTase Sfp of the secondary metabolism can thus convert the ACP of primary Fig. 3 , D and E, and Table III) . The values for low ACP concentrations are in good agreement with those determined for the interaction of Sfp with E. coli ACP (K m of 6 M and k cat of 5.8 min Ϫ1 ) (5). We next tested the D-alanyl carrier protein DCP and a PCP for their ability to serve as substrates for AcpS and/or Sfp. Therefore, the dltC gene encoding DCP was cloned and expressed as a His 6 tag fusion. As a representative of PCPs, we chose the excised TycC3-PCP domain of the multimodular tyrocidine NRPS (19) . As shown in Fig. 4 , Sfp recognized both acyl carrier proteins as substrate, whereas AcpS could only modify DCP.
Identification of a Second ACP in B. subtilis, AcpK, Which Is Only Modified by Sfp-The B. subtilis genome project has confirmed the presence of the previously described gene acpA coding for ACP of fatty acid synthesis (22) . We have reexamined the regions of the genome that harbor the clusters for secondary metabolite production in a search for possible misannotations of the genome project data. The pksX cluster contains several genes that encode enzymes homologous to fatty acid or polyketide synthases of type II (pksB-I), to polyketide synthases of type I (pksKLMPR), and to nonribosomal peptide synthetases (pksJKNR) (25) (and GenBank TM accession number Z99113). A relatively large gap between pksE and pksF led us to reexamine this region in detail (see Fig. 5A ). Surprisingly, we detected an open reading frame, thereafter designated acpK, that has a 20-bp overlap with the 5Ј-end of pksF. The putative gene product AcpK (82 aa, 9.251 kDa, pI 4.2) showed significant similarities to ACPs, in particular around the conserved serine residue, which serves as the Ppant attachment site (see Fig. 5B ). The highest similarity was found to two 
TABLE III Kinetic constants of B. subtilis AcpS and Sfp toward ACP and AcpK
Substrate K m k cat k cat /K m AcpS Sfp AcpS Sfp AcpS Sfp M min Ϫ1 min Ϫ1 M Ϫ1 Apo-ACP (2-8 M) 0.2 Ϯ 0.3 1.4 Ϯ 0
Phosphopantetheine Transfer in B. subtilis
ACPs, TaB and TaE, that are obviously involved in synthesis of the antibiotic TA in Myxococcus xanthus (53 and 33% identity) (26) . The similarity to B. subtilis and E. coli ACPs was only 18 and 22%, respectively. Fig. 5B shows an alignment of AcpK with these acyl carrier proteins. We were interested to know whether AcpK is a substrate for AcpS or Sfp or even for both. As shown in Fig. 4 , only Sfp, but not AcpS, was capable of converting AcpK into its holo form. Determination of kinetic constants revealed a normal Michaelis-Menten behavior with a K m of 7.9 Ϯ 2.1 M and a k cat of 3.2 Ϯ 0.2 min Ϫ1 (see Fig. 3F and Table III) .
Deletion Mutant of B. subtilis acps-The gene ydcB (363 bp) is predicted to be organized in an operon with the downstream gene ydcC (1,119 bp) encoding a putative protein (42.2 kDa) of unknown function. It is not known whether ydcC is essential or not. We decided to attempt deletion of ydcB regardless of possible polar effects on ydcC. For the deletion, we followed a similar strategy as for E. coli acps. First, a second copy of ydcB was introduced into the amyE locus of the B. subtilis chromosome (see Fig. 2B ) by transforming B. subtilis Mo1099 with pDR67-ydcB and selecting for Cm r transformants. These were subsequently checked for MLS s by restreaking. One of the Cm r and MLS s colonies, HM0451, was chosen for further work. HM0451 was then transformed with a PCR product containing 5Ј and 3Ј regions of the original ydcB gene flanking a spc ϩ cassette that substituted the deleted ydcB (obtained by PCR amplification using pTZ18 -5Ј-⌬ydcB::spc-3Ј as template; see Fig. 6B ). By using the PCR product, only a double crossover recombination, and thus a deletion of ydcB, can lead to Sp r transformants. B. subtilis MR168, JH642, and Mo1099, which are all sfp 0 , were transformed with this PCR product for comparison. As expected, Sp r transformants were only obtained using HM0451, and one of these was named HM0492 (see Fig.  6 for confirmation of genotype by PCR), but not for MR168, JH642, and Mo1099. In control experiments using the circular plasmid pTZ18 -5Ј-⌬ydcB::spc-3Ј for the transformation, high numbers of Sp r transformants were observed for all strains. However, PCR analysis of several of these transformants confirmed that they all resulted only from a single crossover event, leaving the ydcB gene intact (see Fig. 6 ). Importantly, the successful deletion of ydcB in strain HM0492 showed that an eventual polar effect on the downstream gene ydcC is not lethal.
Since Sfp was shown in this study to in vitro modify ACP of B. subtilis, we speculated that ydcB might not be essential in sfp ϩ strains. B. subtilis OKB105 (11) was chosen as a test strain expressing the intact sfp gene at physiological levels (another prominent sfp ϩ strain, the surfactin producer ATCC21332, was found to be already Sp r ). OKB105 was transformed with the PCR product as described above. Indeed, Sp r transformants could be obtained. Several of these strains were chosen for PCR analysis, which confirmed their ydcB::spc ϩ genotype (see Fig. 6 ). One of these strains was designated HM0489. HM0489 still produced surfactin in amounts similar to the parent strain OKB105, as judged by analysis of hemolytic activity on blood agar plates (data not shown). Furthermore, the growth curve patterns of OKB105 and HM0489 were indistinguishable in both rich and minimal (glucose) media (data not shown). These results prove that ydcB is dispensable in sfp ϩ strains. The PPTase of secondary metabolism in B. subtilis can substitute for AcpS of primary metabolism under physiological conditions. DISCUSSION We have investigated the phosphopantetheinylation reaction in Ppant-dependent pathways of primary and secondary metabolism of B. subtilis. This organism employs many acyl car- The asterisks mark the residues that provide contacts between AcpS and ACP of B. subtilis (9) .
rier proteins that need to be converted from the inactive apo into the active holo form by the action of a PPTase. Central to primary metabolism and thus essential for survival of the cell is holo-ACP, which acts as the carrier for intermediates of fatty acid synthesis. Another acyl carrier protein-dependent route involved in cell wall synthesis in B. subtilis is the attachment of D-alanyl to free hydroxyl groups of teichoic acid. The D-alanyl moiety is provided by D-alanyl-Ppant-DCP, which is generated from holo-DCP and the D-alanyl carrier protein ligase DclA. This process, which modulates the overall charge of the cell wall, is not essential for cell survival (27) ; however, as a component of the cell wall synthesis, it should rather be assigned to primary than to secondary metabolism. In addition to ACP and DCP, the B. subtilis genome harbors three large clusters, srfA, pps, and pksX, for the production of secondary metabolites as well as the dhb cluster for the synthesis of the siderophore bacillibactin (28) that is expressed under iron-limiting conditions. These genes make up about 4% of the entire chromosome. The multifunctional NRPSs and PKSs encoded comprise a total of 40 acyl carrier proteins of type I that are embedded as domains within the multidomain enzymes. Upstream of the pksX cluster, we have identified a second type II ACP, designated AcpK, which raises the number of Ppant-dependent acyl carrier proteins to 43 in B. subtilis (see Fig. 2B ).
In contrast to the large number of acyl carrier protein, only two PPTases are present in B. subtilis for their conversion into the holo forms. Sfp of the surfactin NRPS was previously biochemically characterized as an enzyme with broad specificity for its protein partner and therefore found manifold applications for the in vitro or in vivo modification of recombinant NRPSs or PKS. Sfp was able to modify every acyl carrier protein tested so far in vitro including ACP of E. coli FAS. It has been shown to modify the surfactin NRPS (1, 5) , the bacillibactin NRPS (28) , and the fengycin or plipastatin NRPS of B. subtilis. Sfp is thus responsible for the 4Ј-phosphopantetheinylation of all 40 integrated acyl carrier protein of B. subtilis.
At the outset of this work, the second PPTase, encoded by the gene ydcB, was not yet described or characterized. We have identified the gene by sequence homology of the gene product to E. coli AcpS; genetically verified its function as the ACP synthase of B. subtilis by complementation of E. coli acps; and finally overproduced, purified, and biochemically characterized the recombinant protein with its substrates ACP and CoA (see Figs. 3 and 4 ). In agreement with the studies on AcpS of the Gram-positive S. pneumoniae (29) we found two K m values for the substrate apo-ACP, due to a first substrate saturation at low (2- 
Ϫ1 ) is comparable with the K m of E. coli AcpS for its natural substrate (K m ϭ 0.5 M; k cat ϭ 68 min Ϫ1 ) (30) . At higher ACP concentration, the first saturation was overcome, and the second K m of 68 Ϯ 11 M (k cat ϭ 125 Ϯ 9 min Ϫ1 ) was determined. This behavior may also point to a positive cooperativity in binding apo-ACP. The co-crystal structures of AcpS with apo-ACP and CoA suggested that AcpS binds first its co-substrate CoA and then forms the catalytic complex with apo-ACP (9). It seems reasonable in this light that we find a K m for CoA of 5.4 Ϯ 1.5 M that is lower than the (second) K m for apo-ACP. However, further work will be necessary to understand the mechanistic details and the reported differences between the two AcpS enzymes from Gram-positive organisms and that of the Gram-negative E. coli. Interestingly, also with the PPTase Sfp, two similar saturation concentrations of apo-ACP were found. Apo-AcpK displayed normal Michaelis-Menten kinetics as reported for Sfp with other (heterologous) ACPs and PCPs (5).
The homologous E. coli AcpS (33% identity) was previously demonstrated to modify not only its natural substrate ACP but also various heterologous ACPs of type II PKSs (6) Table III ). Furthermore, it was reported for E. coli strain MP4, which is conditionally defective in acps, that apo-ACP could comprise 70% of the total ACP pool under growth-permitting conditions (32) , indicating a tolerance toward significant amounts of the inactive form. We therefore attempted disruption of the ydcB gene encoding AcpS in B. subtilis to answer the question of whether Sfp is also capable of carrying out the same reaction under more stringent, physiological in vivo conditions. The sfp gene is under a very weak constitutive promotor (33) . In perfect agreement with these considerations and the in vitro results, we could delete ydcB in the sfp ϩ strain OKB105 (see Fig. 6 ) but failed to do so in sfp Ϫ strains MR168 and Mo1099. Thus, Sfp can function as a redundant ACP synthase in B. subtilis. We have collected further evidence for the ability of Sfp-like PPTases from the secondary metabolism to complement in vivo the essential function of AcpS. Both Gsp from B. brevis and Sfp could complement E. coli AcpS in vivo. This also indicates that Sfp is probably not the only promiscuous PPTase but rather that this broad specificity is a general feature of enzymes of the Sfp family or at least often encountered here. In fact, our laboratory routinely uses Gsp and Sfp in co-expression experiments in E. coli for modification of various recombinant NRPSs (18, 34) .
The ability of PPTases of the Sfp type, and especially of Sfp itself, to complement the activity of AcpS raises questions both about the evolution of PPTase types and about the need for the presence of an AcpS type enzyme in strains that also contain an enzyme of the Sfp type. From sequence and structural consid-erations, it seems plausible to hypothesize that the Sfp family evolved from the AcpS family by a gene fusion event with subsequent diversification of the two halves. This evolution probably took place when the acyl carrier proteins were fused with the other enzymatic units to become integrated domains of FASs, PKSs, or NRPSs. The new architecture of the resulting large protein templates presumably was inaccessible to AcpS for steric or electrostatic reasons, as was suggested from structural data (9) . Another explanation could be the need for a well defined regulation of the CoA pool (35) , possibly to selectively switch on and off primary and secondary metabolism. This argument could still be valid for E. coli, where Ppant transfer of primary and secondary metabolism are separated, but seems irrelevant for B. subtilis in the light of our results. If regulatory aspects are not crucial, then one could expect that PPTases of the AcpS type should gradually get lost from strains also harboring an Sfp type enzyme, as we have experimentally simulated with the acps deletion mutant of B. subtilis. In fact, such strains can be encountered in the pool of microorganisms whose complete genome sequence has been determined. The entire genome of the Gramnegative Pseudomonas aeruginosa, for example, obviously contains only one PPTase encoding gene, whose gene product belongs to the Sfp type (242 aa, 12% identical to Sfp, accession number AAG04554). The Pseudomonas genome is rich in ACPs and NRPSs. The cyanobacterium Synochocystis PCC6803 also seems to lack an enzyme of the AcpS type but contains one of the Sfp type (246 aa, 21% identical to Sfp, accession number 1001183). Strikingly, however, this organism is obviously devoid of any secondary metabolism genes encoding PKSs or NRPSs, since we could only detect the homologue to ACP. The genome of Bacillus halodurans reveals, similar to B. subtilis, one PPTase gene of each group, encoding an AcpS and a Sfp homologue (119 and 214 aa, accession numbers BAB04327 and BAB05571, 48 and 21% identical to AcpS and Sfp, respectively), but again, the fatty acid ACP seems to be the only acyl carrier protein present.
We note that the wide distribution and the ability of PPTases of the Sfp type to complement the essential function of AcpS in vivo may pose significant problems in approaches to direct new inhibitors against AcpS, which was proposed as an attractive antimicrobial target (9, 10) . Therefore, a potential inhibitor would need to be of broad enough specificity toward both types of PPTases.
The role of AcpK in B. subtilis is unknown, but a function in polyketide assembly can be deduced from its location within the large pksX cluster (see Fig. 5 ). There are striking similarities between the pksX cluster, which is completely uncharacterized except for its sequence, and the reported parts of the cluster responsible for the biosynthesis of the antibiotic TA in M. xanthus (26, 36) . Not only does AcpK display the highest similarities to the two ACPs, TaB and TaE, but also PksG is highly similar to TaC and TaF, all of which are predicted from sequence analysis to encode 3-hydroxy-3-methyl-glutaryl-CoA synthases. Furthermore, the enzyme PksK, a mixed NRPS/ PKS, has an identical domain organization (T-C-A-T-PKS) as the fragment that is known from the enzyme TA1 (-C-A-T-PKS; the N terminus has not yet been determined) (26) . We found that the signature sequences of the A-domains of both NRPS enzymes are almost identical and are predicted to confer glycine specificity (37) , which would fit well with the glycine residue found in the antibiotic TA. If this analogy extends further, one could speculate that the starter in the biosynthesis of the pksX product is the same as in antibiotic TA (26) . At present, however, it cannot be ruled out that AcpK is the donor of the fatty acid for the biosynthesis of surfactin and fengycin.
Another candidate for this role would be the fatty acid ACP itself, since the fatty acid moiety of these latter antibiotics is an intermediate in fatty acid biosynthesis.
In conclusion, the many acyl carrier proteins in B. subtilis are converted into their active holo form by only two PPTases, AcpS and Sfp. Obviously, in this Gram-positive bacterium, a strict separation of the different biosynthetic pathways on the level of Ppant transfer, as reported for E. coli, is not necessary. AcpS is not essential for cell survival, because Sfp of secondary metabolism can complement its function in primary metabolism.
